EDSA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Edesa Biotech Inc

NASDAQ | EDSA

2.11

USD

$0.00

(

0.00%

)

At Close (As of Oct 28, 2025)

$19.31M

Market Cap

-

P/E Ratio

-1.24

EPS

$4.49

52 Week High

$1.55

52 Week Low

HEALTHCARE

Sector

EDSA Chart

Recent Chart
Price Action

EDSA Technicals

Tags:

EDSA Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$186K
Total Revenue $0
Cost Of Revenue $186K
Costof Goods And Services Sold $186K
Operating Income -$7M
Selling General And Administrative $4.1M
Research And Development $2.9M
Operating Expenses $7M
Investment Income Net -
Net Interest Income $153K
Interest Income $153K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $186K
Income Before Tax -$6.2M
Income Tax Expense $800
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$6.2M
Ebitda -$6M
Net Income -$6.2M

Revenue & Profitability

Earnings Performance

EDSA Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $3.8M
Total Current Assets $1.7M
Cash And Cash Equivalents At Carrying Value $1M
Cash And Short Term Investments $1M
Inventory -
Current Net Receivables $271K
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.1M
Intangible Assets Excluding Goodwill $2.1M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $367K
Other Non Current Assets -
Total Liabilities $1.8M
Total Current Liabilities $1.8M
Current Accounts Payable $1.8M
Deferred Revenue -
Current Debt -
Short Term Debt $20K
Total Non Current Liabilities $126K
Capital Lease Obligations $20K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $20K
Other Current Liabilities $1.8M
Other Non Current Liabilities -
Total Shareholder Equity $2M
Treasury Stock -
Retained Earnings -$59M
Common Stock $47M
Common Stock Shares Outstanding $3.2M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$4.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $186K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $592K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$6.2M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$186K
Total Revenue $0
Cost Of Revenue $186K
Costof Goods And Services Sold $186K
Operating Income -$7M
Selling General And Administrative $4.1M
Research And Development $2.9M
Operating Expenses $7M
Investment Income Net -
Net Interest Income $153K
Interest Income $153K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $186K
Income Before Tax -$6.2M
Income Tax Expense $800
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$6.2M
Ebitda -$6M
Net Income -$6.2M

EDSA News

EDSA Profile

Edesa Biotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Edesa Biotech Inc. (EDSA), a clinical-stage biopharmaceutical company based in Markham, Canada, is dedicated to developing innovative therapies targeting inflammatory and immune-related diseases. With a strong focus on unmet medical needs, Edesa's pipeline features proprietary technologies aimed at advancing treatment options for dermatological and gastrointestinal disorders. As the company progresses through its clinical trials, it is poised to establish a significant presence in the biotherapeutics sector, underpinned by a commitment to enhancing patient outcomes through cutting-edge scientific discovery.

XHLD
+96.21%
$0.54
GPUS
+20.52%
$0.60
BYND
+14.92%
$2.08
VHAI
+33.33%
$0.00
ASST
-10.67%
$1.46
VSEE
+186.83%
$1.77
NOK
+24.63%
$7.92
ADTX
-48.45%
$0.10
SOFI
+1.55%
$30.46
ATCH
+35.68%
$0.51
KDLY
+20.23%
$1.01
FRGT
+25.63%
$1.54
CAN
-14.08%
$1.49
NVDA
+1.54%
$194.44
INTC
+5.32%
$41.64
YDKG
-7.68%
$0.06
RGTI
+3.60%
$40.24
WULF
+21.48%
$16.57
AXDX
-61.36%
$0.03
DNN
+11.87%
$3.11
F
-0.52%
$13.19
CODX
-53.57%
$0.58
PYPL
+9.66%
$77.04
BURU
-3.03%
$0.38
NAKA
-7.54%
$0.93
ADAP
-15.14%
$0.05
LUNG
+48.07%
$2.31
TSLA
+2.92%
$465.64
JEM
+24.63%
$0.36
DVLT
-2.44%
$3.19
WTO
-7.16%
$0.05
RMBL
+60.50%
$3.21
PLUG
-2.70%
$2.88
AMZN
+1.23%
$226.97
ADD
-25.47%
$0.05
RELI
+12.66%
$1.07
SRM
+53.27%
$10.30
EHGO
-17.32%
$0.42
JBLU
-11.41%
$4.18
LAES
+5.13%
$7.16
QBTS
-0.65%
$34.81
TDIC
+22.57%
$0.51
BITF
+1.98%
$4.63
CJET
-2.87%
$0.11
NEHC
+6.99%
$6.27
AMD
+1.11%
$262.56
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
T
+0.29%
$25.60
TLRY
-3.40%
$1.42
HBAN
-1.11%
$15.46
GRAB
-1.96%
$6.00
AAL
-2.31%
$13.10
ERIC
+2.33%
$9.65
WBD
-0.52%
$21.04
AFMD
-34.94%
$0.18
ABEV
-0.67%
$2.20
YMAT
+37.52%
$1.18
SMR
+13.74%
$44.02
VALE
+1.83%
$11.67
RF
0.00%
$24.24
RIG
-2.07%
$3.78
APLD
+6.37%
$36.54
GLXY
-6.46%
$37.93
ACHR
+0.58%
$11.40
OPI
-16.97%
$0.20
IONZ
+5.11%
$3.70
QS
-3.04%
$15.78
RXRX
-4.12%
$6.04
MARA
+0.63%
$19.68
KLG
-9.05%
$13.35
CIFR
+4.86%
$21.54
RR
+0.68%
$5.91
GRYP
-10.38%
$1.38
LUMN
+2.43%
$9.58
QUBT
-0.25%
$15.68
MODV
-25.22%
$0.43
UPS
+7.75%
$96.13
SCWO
+9.19%
$0.42
PFE
-0.90%
$24.54
SNAP
-0.94%
$7.83
AAPL
+0.05%
$268.95
ETHD
+3.61%
$3.44
JOBY
-1.22%
$16.09
MSFT
+2.11%
$542.78
CCL
-4.60%
$28.06
NIO
-0.42%
$7.01
VIVK
-6.47%
$0.27
SMCI
+3.95%
$53.61
RIVN
+0.48%
$13.47
GOOGL
-0.79%
$267.12
BBD
-0.14%
$3.39
ONDS
-3.98%
$7.22
PLTR
-0.10%
$188.98
BTBT
-1.25%
$3.94
UUUU
+8.16%
$20.66
POLA
+7.65%
$3.94
BTG
+0.12%
$4.96
LX
-22.27%
$4.01
STLA
+2.42%
$11.20
XHLD
+96.21%
$0.54
GPUS
+20.52%
$0.60
BYND
+14.92%
$2.08
VHAI
+33.33%
$0.00
ASST
-10.67%
$1.46
VSEE
+186.83%
$1.77
NOK
+24.63%
$7.92
ADTX
-48.45%
$0.10
SOFI
+1.55%
$30.46
ATCH
+35.68%
$0.51
KDLY
+20.23%
$1.01
FRGT
+25.63%
$1.54
CAN
-14.08%
$1.49
NVDA
+1.54%
$194.44
INTC
+5.32%
$41.64
YDKG
-7.68%
$0.06
RGTI
+3.60%
$40.24
WULF
+21.48%
$16.57
AXDX
-61.36%
$0.03
DNN
+11.87%
$3.11
F
-0.52%
$13.19
CODX
-53.57%
$0.58
PYPL
+9.66%
$77.04
BURU
-3.03%
$0.38
NAKA
-7.54%
$0.93
ADAP
-15.14%
$0.05
LUNG
+48.07%
$2.31
TSLA
+2.92%
$465.64
JEM
+24.63%
$0.36
DVLT
-2.44%
$3.19
WTO
-7.16%
$0.05
RMBL
+60.50%
$3.21
PLUG
-2.70%
$2.88
AMZN
+1.23%
$226.97
ADD
-25.47%
$0.05
RELI
+12.66%
$1.07
SRM
+53.27%
$10.30
EHGO
-17.32%
$0.42
JBLU
-11.41%
$4.18
LAES
+5.13%
$7.16
QBTS
-0.65%
$34.81
TDIC
+22.57%
$0.51
BITF
+1.98%
$4.63
CJET
-2.87%
$0.11
NEHC
+6.99%
$6.27
AMD
+1.11%
$262.56
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
T
+0.29%
$25.60
TLRY
-3.40%
$1.42
HBAN
-1.11%
$15.46
GRAB
-1.96%
$6.00
AAL
-2.31%
$13.10
ERIC
+2.33%
$9.65
WBD
-0.52%
$21.04
AFMD
-34.94%
$0.18
ABEV
-0.67%
$2.20
YMAT
+37.52%
$1.18
SMR
+13.74%
$44.02
VALE
+1.83%
$11.67
RF
0.00%
$24.24
RIG
-2.07%
$3.78
APLD
+6.37%
$36.54
GLXY
-6.46%
$37.93
ACHR
+0.58%
$11.40
OPI
-16.97%
$0.20
IONZ
+5.11%
$3.70
QS
-3.04%
$15.78
RXRX
-4.12%
$6.04
MARA
+0.63%
$19.68
KLG
-9.05%
$13.35
CIFR
+4.86%
$21.54
RR
+0.68%
$5.91
GRYP
-10.38%
$1.38
LUMN
+2.43%
$9.58
QUBT
-0.25%
$15.68
MODV
-25.22%
$0.43
UPS
+7.75%
$96.13
SCWO
+9.19%
$0.42
PFE
-0.90%
$24.54
SNAP
-0.94%
$7.83
AAPL
+0.05%
$268.95
ETHD
+3.61%
$3.44
JOBY
-1.22%
$16.09
MSFT
+2.11%
$542.78
CCL
-4.60%
$28.06
NIO
-0.42%
$7.01
VIVK
-6.47%
$0.27
SMCI
+3.95%
$53.61
RIVN
+0.48%
$13.47
GOOGL
-0.79%
$267.12
BBD
-0.14%
$3.39
ONDS
-3.98%
$7.22
PLTR
-0.10%
$188.98
BTBT
-1.25%
$3.94
UUUU
+8.16%
$20.66
POLA
+7.65%
$3.94
BTG
+0.12%
$4.96
LX
-22.27%
$4.01
STLA
+2.42%
$11.20
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.